Pharmaceuticals, Biotechnology and Life Sciences
Dr.Reddy’s has entered into a definitive agreement toacquire a portfolio of 42 approved, non-marketed Abbreviated New DrugApplications (ANDAs) in the U.S.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) todayannounced the launch of a generic version of AndroGel ®i(testosterone gel) 1.62% CIII in the U.S.
Ophtotech entered into an exclusive global licenseagreement for rights to developand commercialize novel adeno-associated virus (AAV) gene therapyproduct candidates for the treatment of Best vitelliform maculardystrophy.
CAMBRIDGE, Mass.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the…
As the U.S. continues to grapple with solutions to the national opioidaddiction epidemic, Brentwood-based Corizon Health is preparing to offera successful treatment pilot to additional communities the companyserves across the U.S.
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on April 3, 2019 the Compensation Committee of…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today…
WASHINGTON–(BUSINESS WIRE)–Today, Citizens Against Government Waste (CAGW) released an analysis of misguided provisions in Gov. Tim Walz’s (D-Minn.) budget that…
Bio-Rad has bagged clearance from the U.S. Food and DrugAdministration (FDA) for its IH-500, an automated randomaccess system for blood typing and screening.
The U.S. Food and Drug Administration Monday approved Dovato, two-drug, fixed-dose, complete regimen for HIV-infected adults who have never received treatment for HIV.